Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
VitaSpring Biomedical (VSBC) Stock Price & Analysis
2 Followers
VSBC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.01 - $16.00
Previous Close$15.5
Volume42.00
Average Volume (3M)N/A
Market Cap
$3.20B
Enterprise Value$3.20B
Total Cash (Recent Filing)$41.66K
Total Debt (Recent Filing)$45.90K
Price to Earnings (P/E)―
Beta1.06
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding206,520,030
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.43
R-Squared0.05
Alpha0.14
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue642.90
Enterprise Value/Gross Profit1.55K
Enterprise Value/Ebitda2.07K
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VSBC FAQ
What was VitaSpring Biomedical’s price range in the past 12 months?
VitaSpring Biomedical lowest stock price was $11.01 and its highest was $16.00 in the past 12 months.
What is VitaSpring Biomedical’s market cap?
Currently, no data Available
When is VitaSpring Biomedical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were VitaSpring Biomedical’s earnings last quarter?
Currently, no data Available
Is VitaSpring Biomedical overvalued?
According to Wall Street analysts VitaSpring Biomedical’s price is currently Overvalued.
Does VitaSpring Biomedical pay dividends?
VitaSpring Biomedical does not currently pay dividends.
What is VitaSpring Biomedical’s EPS estimate?
VitaSpring Biomedical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VitaSpring Biomedical have?
VitaSpring Biomedical has 206,520,030 shares outstanding.
What happened to VitaSpring Biomedical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VitaSpring Biomedical?
Currently, no hedge funds are holding shares in VSBC
---
VitaSpring Biomedical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
VitaSpring Biomedical
VitaSpring Biomedical Co Ltd is a start-up business company. The company's objective is to develop new drugs in cell medicine. The company also plans to produce X.MSC cytopharmaceuticals.
---
Technical Analysis
---